Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.36 USD | 0.00% | +3.37% | -38.72% |
30/04 | Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating | MT |
26/04 | Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.72% | 58Cr | |
+20.79% | 8.56TCr | |
-28.75% | 7.06TCr | |
+3.10% | 2.7TCr | |
-6.19% | 1.8TCr | |
+2.07% | 1.76TCr | |
+2.10% | 1.56TCr | |
+7.06% | 1.35TCr | |
+10.35% | 1.34TCr | |
+71.31% | 1.32TCr |
- Stock Market
- Equities
- ACCD Stock
- News Accolade, Inc.
- Transcript : Accolade, Inc., Q2 2024 Earnings Call, Oct 04, 2023